AWM Investment Company’s Avadel Pharmaceuticals AVDL Stock Holding History

AWM Investment Company’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-316,189	Closed	-$6.81M	–	101
2025 Q4	$6.81M	Hold	316,189	–	–	0.66%	46
2025 Q3	$4.83M	Hold	316,189	–	–	0.45%	57
2025 Q2	$2.8M	Buy	316,189 +275,189	+671%	+$2.42M	0.31%	72
2025 Q1	$321K	Buy	+41,000	New	+$343K	0.04%	88

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

AWM Investment Company's AVDL Position: Q1 2026 in Review

AWM Investment Company sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 316,189 shares — an estimated $6.81M sold.

AWM Investment Company first reported a position in AVDL in Q1 2025 and held it in 4 quarters. The position peaked at $6.81M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

AWM Investment Company reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
AWM Investment Company sold 316,189 Avadel Pharmaceuticals shares in Q1 2026, an estimated $6.81M.
AWM Investment Company first reported a position in Avadel Pharmaceuticals in Q1 2025 and held it in 4 quarters.
AWM Investment Company's Avadel Pharmaceuticals position peaked at $6.81M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.